Reports from University of Utah Health Add New Data to Findings in Antiarrhythmic Agents [Expedited Loading With Intravenous Sotalol Is Safe and Feasible-primary Results of the Prospective Evaluation Analysis and Kinetics of Iv Sotalol (Peaks)...].

A recent study conducted by researchers at the University of Utah Health evaluated the safety and feasibility of intravenous (IV) sotalol loading for atrial arrhythmias. The study found that IV sotalol loading is safe and feasible, with low rates of adverse events and shorter hospitalizations. Of the 167 patients enrolled in the study, 99% were admitted for sotalol initiation, and the mean length of stay was 1.1 days. However, the researchers noted that more data are needed to determine the minimal duration required for monitoring in the hospital. This study provides valuable insights into the use of IV sotalol for atrial arrhythmias. [Extracted from the article]